Amneal Pharmaceuticals (AMRX) Leases (2019 - 2025)
Historic Leases for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Q3 2025 value amounting to $54.4 million.
- Amneal Pharmaceuticals' Leases fell 540.92% to $54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.4 million, marking a year-over-year decrease of 540.92%. This contributed to the annual value of $56.4 million for FY2024, which is 3038.14% up from last year.
- According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Leases is $54.4 million, which was down 540.92% from $55.1 million recorded in Q2 2025.
- In the past 5 years, Amneal Pharmaceuticals' Leases registered a high of $67.5 million during Q1 2021, and its lowest value of $43.3 million during Q4 2023.
- Its 5-year average for Leases is $59.7 million, with a median of $60.4 million in 2021.
- In the last 5 years, Amneal Pharmaceuticals' Leases plummeted by 2287.56% in 2023 and then surged by 3038.14% in 2024.
- Over the past 5 years, Amneal Pharmaceuticals' Leases (Quarter) stood at $60.4 million in 2021, then fell by 7.04% to $56.1 million in 2022, then decreased by 22.88% to $43.3 million in 2023, then skyrocketed by 30.38% to $56.4 million in 2024, then decreased by 3.57% to $54.4 million in 2025.
- Its Leases stands at $54.4 million for Q3 2025, versus $55.1 million for Q2 2025 and $56.0 million for Q1 2025.